Surrogate End Points [qlco]
development [phsf]
Drugs [phsu]
Risk [qlco]
Cancer [neop]
This [euka]
Paper [mnob]
Scientific [ocdi]
Basis [ftcn]
Possible [qlco]
strategy [menp]
Apply [hlca]
Surrogate End Points [qlco]
Chemopreventive [qlco]
Drug Development [bmod]
Potential [qlco]
Surrogate End Points [qlco]
Cancer [neop]
Incidence [qnco]
Tissue [tisu]
Cellular [cell]
Molecular [qlco]
Levels [qlco]
Genotypic [orga]
Biomarkers [clna]
To [qlco]
establish [qlco]
Chemopreventive [qlco]
Efficacy [qlco]
Controlled Clinical Trials, Randomized [resa]
placebo [topp]
Expected [idcn]
Cases [ftcn]
Critical [qlco]
Ensure [food]
Biomarker [clna]
lesions [fndg]
PREVENT [phsu]
lesions [fndg]
PREVENT [phsu]
Potential [qlco]
progress [ftcn]
This [euka]
Phenotype [orga]
Genotype [orga]
Target [ftcn]
Tissue [tisu]
Agent [chvf]
treated [topp]
Subject [grup]
New [tmco]
Remaining [qlco]
Equivalent [qlco]
Show [inpr]
progression [patf]
placebo [topp]
treated [topp]
Subject [grup]
National Cancer Program [hcro]
institute [orgt]
Chemoprevention [topp]
Histological [ftcn]
Modulation [spco]
Intraepithelial Neoplasia [neop]
Primary Endpoint [irda]
Chemoprevention [topp]
Trial [resa]
Give [ftcn]
High priority [tmco]
Biomarkers [clna]
measuring [qlco]
Specific [qlco]
General [spco]
Genotypic [orga]
Carcinogenesis [neop]
progression [patf]
Model [inpr]
Targeted [ftcn]
Cancer [neop]
Progressive [ftcn]
Genomic Instability [comd]
Measured [qlco]
Loss [qnco]
Heterozygosity [orga]
Amplification [mbrt]
Specific [qlco]
Microsatellite [bacs, nnon]
Locus [gngm]
Potential [qlco]
Surrogate End Points [qlco]
Occur [acty]
Early [tmco]
Carcinogenesis [neop]
Analyzed [resa]
Nearby [qlco]
Normal Tissue [tisu]
APPEAR [qlco]
Biomarkers [clna]
Proliferation [patf]
Differentiation [celf]
Index [inpr]
Specific [qlco]
Gene [gngm]
General [spco]
Chromosome [celc]
Damage [inpo]
Cell Growth [celf]
regulatory [rnlw]
molecules [sbst]
Biochemical [ftcn]
Activities [acty]
enzyme inhibition [dsyn]
Serum [bdsu]
Biomarkers [clna]
monitor [hlca]
Prostate-Specific Antigen [aapp, enzy, imft]
accessibility [qlco]
Chemopreventive [qlco]
drug effects [ftcn]
Test [lbpr]
Agent [chvf]
Measured [qlco]
Tissue [tisu]
serum estrogen [lbpr]
Level [qlco]
studies [lbpr]
Steroidal Aromatase Inhibitor [phsu]
Initial [tmco]
Study [mnob]
Expected [idcn]
To [qlco]
Expand [spco]
List [cnce]
Surrogate End Points [qlco]
Future [tmco]
Continued [idcn]
Discussion [topp]
National Cancer Institute [hcro]
Food and Drug Administration [hcro]
Industry [ocac]
Academia [orgt]
Needed [qlco]
To [qlco]
Ensure [food]
Surrogate End Point [qlco]
Based [ftcn]
Chemoprevention [topp]
Indications [idcn]
